Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06276595 · ClinicalTrials.gov registry record · NA
Telling Our Daughters Our Story
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT06276595 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 183 participants.
The verdict
NCT06276595, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk and protective factors for early substance use and sexual debut through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the TODOS program effectively reduces risk factors and improves protective factors associated with early substance use and sexual debut, with long term goals of reducing teen pregnancy and teen substance use.
Interventions
- BEHAVIORAL Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)
- BEHAVIORAL Control condition - 3 Monthly Group Activities in the Community
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2019-03-30 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06276595
The ClinicalTrials.gov registry entry for NCT06276595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS) is the first listed.
NCT06276595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06276595 about?
NCT06276595 is a clinical study titled "Telling Our Daughters Our Story". The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on...
What is the current status of trial NCT06276595?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2019-03-30. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT06276595?
The interventions under investigation include: Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS) (BEHAVIORAL), Control condition - 3 Monthly Group Activities in the Community (BEHAVIORAL).
Who is sponsoring clinical trial NCT06276595?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.